Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...

While all GLP-1 medications share the same fundamental mechanism of action, variations in molecular structure can influence their effectiveness and duration of action. Longer-acting agents like ...

Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Unlock the latest advancements in obesity treatment. Expert insights reveal groundbreaking medical breakthroughs and ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off-label use by celebrities and social media influencers for cutting ...